|
|
|
|
|
|
|
By Rachel Grabenhofer, Chief Editor, Clinical Supply Leader
|
Understanding protocol requirements is only part of the execution challenge. Here, experts explain how intent becomes operational plans, system configurations, and supply strategy.
|
|
|
|
|
|
|
|
By Kendra Orjada, Merck & Co
|
Clinical trial policy is shifting research closer to patients, creating new demands for forecasting, distribution, inventory, accountability, cold chain, and cross-functional planning.
|
|
|
|
|
|
|
|
By Dr. Mohammad Zaher Shehab, Elevion Pharma
|
EU and U.K. clinical trial rules are evolving separately. Here’s what sponsors need to consider across QP release, labeling, importation, and supply continuity.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How Compliance Is Understood Over Time
|
|
By Joseph Weiford
|
Compliance shifts from single shipments to patterns over time. Consistency in identity, documentation, and rationale reveals structure that makes decisions traceable.
|
|
|
|
|
.png){kind=logo}
